OpenCapital
Beta
Calendar
Stocks
Metrics
Connect AI
/
Stocks
Watchlist
W
Sign In
Toggle navigation menu
Stocks
Edwards Lifesciences
Balance Sheet Statement
Business Combination, Contingent Consideration, Liability, Current
Discontinued — last reported Q4 '23
Other
Business Combination, Contingent Consideration, Liability, Current
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Other
First reported
Q4 2022
Last reported
Q4 2023
Metric ID:
other_business_combination_contingent_consideration_liab_d9be34
Historical Data
2 periods
Quarterly
Annual
Q4 '25
Q1 '26
Value
$0.00
$7.50M
Range
$0.00 – $7.50M
Frequently Asked Questions
What is Edwards Lifesciences's business combination, contingent consideration, liability, current?
Edwards Lifesciences (EW) reported business combination, contingent consideration, liability, current of $7.50M in Q1 2026.